EyePoint Pharmaceuticals Files 8-K
Ticker: EYPT · Form: 8-K · Filed: Mar 4, 2025 · CIK: 1314102
| Field | Detail |
|---|---|
| Company | Eyepoint Pharmaceuticals, Inc. (EYPT) |
| Form Type | 8-K |
| Filed Date | Mar 4, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, 8-K, financial-reporting
Related Tickers: EYPT
TL;DR
EYPT filed an 8-K on 3/4/25. Nothing major, just standard reporting.
AI Summary
EyePoint Pharmaceuticals, Inc. filed an 8-K on March 4, 2025, reporting on other events and financial statements. The company, formerly known as pSivida Corp. and pSivida LTD, is incorporated in Delaware and headquartered in Watertown, Massachusetts.
Why It Matters
This filing provides an update on EyePoint Pharmaceuticals' corporate events and financial reporting, which is crucial for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — This filing appears to be routine corporate reporting and does not indicate any immediate significant risks or changes.
Key Numbers
- 000-51122 — SEC File Number (Identifies the company's filing with the SEC.)
- 26-2774444 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- EyePoint Pharmaceuticals, Inc. (company) — Registrant
- pSivida Corp. (company) — Former company name
- pSivida LTD (company) — Former company name
- March 04, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Watertown, Massachusetts (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing is for reporting 'Other Events' and 'Financial Statements and Exhibits' as of March 4, 2025.
When was EyePoint Pharmaceuticals, Inc. previously known?
The company was formerly known as pSivida Corp. and prior to that, pSivida LTD.
Where are EyePoint Pharmaceuticals, Inc.'s principal executive offices located?
The principal executive offices are located at 480 Pleasant Street, Suite B300, Watertown, Massachusetts 02472.
What is the exact date of the report for this 8-K filing?
The date of the report, and the earliest event reported, is March 04, 2025.
In which U.S. state is EyePoint Pharmaceuticals, Inc. incorporated?
EyePoint Pharmaceuticals, Inc. is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 4, 2025 regarding EyePoint Pharmaceuticals, Inc. (EYPT).